Corbion N.V. (AMS:CRBN)
Netherlands
· Delayed Price · Currency is EUR | Market Cap | 1.08B |
| Revenue (ttm) | 1.27B |
| Net Income (ttm) | 74.80M |
| Shares Out | 57.63M |
| EPS (ttm) | 1.27 |
| PE Ratio | 14.76 |
| Forward PE | 13.47 |
| Dividend | 0.64 (3.43%) |
| Ex-Dividend Date | May 15, 2026 |
| Volume | 119,397 |
| Average Volume | 137,282 |
| Open | 18.69 |
| Previous Close | 18.65 |
| Day's Range | 18.58 - 18.92 |
| 52-Week Range | 16.16 - 21.64 |
| Beta | 0.94 |
| RSI | 49.12 |
| Earnings Date | Jul 31, 2026 |
About Corbion
Corbion N.V. provides lactic acid and derivatives, food preservation solutions, functional ingredient systems, and algae-derived nutritional ingredients in the Netherlands, the United States, Asia, rest of Americas, the rest of Europe, the Middle East, and Africa. It operates in two segments, Functional Ingredients & Solutions, and Health & Nutrition. The company offers antioxidants, fermentation and preservation ingredients, flavors, fortification, functional blends, and lactic acid lactates and derivatives; AlgaPrime DHA, an omega-3 sourcing ... [Read more]
Financial Performance
In 2025, Corbion's revenue was 1.27 billion, a decrease of -1.61% compared to the previous year's 1.29 billion. Earnings were 74.80 million, a decrease of -61.08%.
Financial StatementsNews
Corbion Earnings Call Transcript: Q1 2026
Q1 2026 results showed lower sales and margins versus a strong prior year, but momentum is building with robust demand in core segments and cost reductions set to drive improvement from Q2. Full-year guidance is reaffirmed, with strong cash generation and margin recovery expected.
Correction: Corbion announces quarterly sales of € 293.7m and Adjusted EBITDA of € 37.8m; maintains full-year outlook
Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through the application of science, today publishes its results for Q1 2026 ending 31 March.
Corbion announces quarterly sales of € 293.7m and Adjusted EBITDA of € 37.8m; maintains full-year outlook
Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through the application of science, today publishes its results for Q1 2026 ending 31 March.
Corbion published agenda for AGM
Corbion has published its agenda for the upcoming Annual General Meeting of Shareholders (AGM) to be held on 13 May 2026 . The full AGM agenda together with explanatory notes is available on Corbion's...
Corbion Earnings Call Transcript: H2 2025
Delivered strong organic growth, improved profitability, and robust free cash flow in 2025, with EPS up 63% and a proposed EUR 1 per share dividend. 2026 guidance targets 3%-6% organic sales growth, 17% EBITDA margin, and continued portfolio focus.
Corbion announces strong full-year 2025 results with +26.7% organic Adjusted EBITDA growth, +63.3% EPS growth, and €90.8 million in FCF; announces special dividend
Corbion, the Amsterdam-listed sustainable food-ingredients company that champions preservation through application of science, today publishes its results for the year ending 31 December 2025.
Corbion Transcript: CMD 2025
Advance 2025 goals were met, with margin expansion and portfolio transformation. Bright 2030 targets 3%-6% annual sales growth, 18% EBITDA margin by 2028, and EUR 270 million free cash flow, focusing on natural preservation, nutrition, and biomedical polymers, while exiting non-core areas.
Corbion unveils BRIGHT 2030 strategy to lead in sustainable specialty food-ingredients; outlining its strategic path and medium-term financial targets
Corbion, the Amsterdam-listed sustainable food-ingredients company that champions preservation through application of science, will hold its Capital Markets Day for analysts and investors via live web...
Corbion reports the end of its share buyback program to cover commitments under its long-term employee incentive plan
Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through application of science, today announces that it has completed the share buyback program which it start...
Corbion reports the progress of its share buyback program 3 November – 7 November 2025
Corbion hereby reports the transaction details related to its share buyback program announced on 1 September 2025. During the week of 3 November up to and including 7 November 2025 a total of 124.786 ...
Corbion signs a new debt issuance for USD 100 million in the US Private Placement market
Corbion announces the signing of a Note Purchase Agreement for a total debt issuance of USD 100 million in the US Private Placement (USPP) market, with a fixed interest rate of 5.11% and a maturity of...
Corbion reports the progress of its share buyback program 27 October – 31 October 2025
Corbion hereby reports the transaction details related to its share buyback program announced on 1 September 2025. During the week of 27 October up to and including 31 October 2025 a total of 102.003 ...
Corbion announces strong YTD EBITDA growth, and EBITDA margin improvement of +240 bps; full-year outlook maintained
Corbion Q3 2025 Interim Management Statement Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through application of science, today publishes its results for t...
Corbion reports the progress of its share buyback program 20 October – 24 October 2025
Corbion hereby reports the transaction details related to its share buyback program announced on 1 September 2025. During the week of 20 October up to and including 24 October 2025 a total of 22.669 s...
Corbion reports the progress of its share buyback program 13 October – 17 October 2025
Corbion hereby reports the transaction details related to its share buyback program announced on 1 September 2025. During the week of 13 October up to and including 17 October 2025 a total of 29.981 s...
Corbion reports the progress of its share buyback program 6 October – 10 October 2025
Corbion hereby reports the transaction details related to its share buyback program announced on 1 September 2025. During the week of 6 October up to and including 10 October 2025 a total of 35.578 sh...
Corbion reports the progress of its share buyback program 29 September – 3 October 2025
Corbion hereby reports the transaction details related to its share buyback program announced on 1 September 2025. During the week of 29 September up to and including 03 October 2025 a total of 22.839...
Corbion reports the progress of its share buyback program 22 September – 26 September 2025
Corbion hereby reports the transaction details related to its share buyback program announced on 1 September 2025. During the week of 22 September up to and including 26 September 2025 a total of 57.1...
Corbion reports the progress of its share buyback program 15 September – 19 September 2025
Corbion hereby reports the transaction details related to its share buyback program announced on 1 September 2025. During the week of 15 September up to and including 19 September 2025 a total of 37.2...
Corbion reports the progress of its share buyback program 8 September – 12 September 2025
Corbion hereby reports the transaction details related to its share buyback program announced on 1 September 2025. During the week of 8 September up to and including 12 September 2025 a total of 28.80...
Corbion announces share buyback program to cover commitments under the long-term employee incentive plan
Corbion announces a share buyback program under which it plans to repurchase ordinary shares of Corbion N.V. for a maximum total amount of € 10 million and a maximum of 580.383 shares (based on the cl...
Corbion proposes to appoint Per Falholt to the Supervisory Board
Corbion's Supervisory Board announces it has nominated Per Falholt for appointment to the Supervisory Board for a term of four years as of the Annual General Meeting of Shareholders (AGM) in May 2026.
Corbion and Kuehnle AgroSystems join forces to develop natural Astaxanthin from algae fermentation
Corbion, the Amsterdam-based global leader in sustainable ingredients, and US-based biotech company Kuehnle AgroSystems (KAS) have entered into a strategic partnership to develop and commercialize a h...
Corbion Earnings Call Transcript: H1 2025
Organic sales grew 2.9% to €645M in H1 2025, with adjusted EBITDA up nearly 24% and margin rising 300 bps to 16.5%. Guidance for FY 2025 is reaffirmed, targeting 2–6% volume growth and over 25% EBITDA growth, supported by operational efficiencies and strong demand in key segments.
Corbion delivers Sales of € 645.6 million and an improvement of EBITDA margins of +300 bps for first-half 2025; full-year outlook maintained
Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through application of science, today publishes its half-year 2025 results ending 30 June 2025.